000 01267 a2200361 4500
005 20250514030226.0
264 0 _c20021021
008 200210s 0 0 fre d
022 _a0761-8417
040 _aNLM
_beng
_cNLM
100 1 _aGrahek, D
245 0 0 _a[Positron emission tomography (PET) with [18F]-FDG in bronchopulmonary cancer and its impact on medical decision at the time of diagnosis, staging, or recurrence evaluation].
_h[electronic resource]
260 _bRevue de pneumologie clinique
_cDec 2001
300 _a393-403 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aDiagnosis, Differential
650 0 4 _aFalse Negative Reactions
650 0 4 _aFalse Positive Reactions
650 0 4 _aFluorodeoxyglucose F18
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdiagnostic imaging
650 0 4 _aNeoplasm Recurrence, Local
_xdiagnostic imaging
650 0 4 _aNeoplasm Staging
650 0 4 _aRadiopharmaceuticals
650 0 4 _aTomography, Emission-Computed
700 1 _aMontravers, F
700 1 _aMayaud, C
700 1 _aRegnard, J F
700 1 _aKerrou, K
700 1 _aYounsi, N
700 1 _aTalbot, J N
773 0 _tRevue de pneumologie clinique
_gvol. 57
_gno. 6
_gp. 393-403
999 _c11828743
_d11828743